Previous Article | Next Article ![]()
Applied and Environmental Microbiology, August 2000, p. 3646-3649, Vol. 66, No. 8
Division of
Microbiology1 and Division of
Chemistry,3 National Center for Toxicological
Research, U.S. Food and Drug Administration, Jefferson, Arkansas
72079, and Department of Metabolism and Pharmacokinetics,
Bristol-Myers Squibb, Princeton, New Jersey 085022
Received 18 January 2000/Accepted 16 May 2000
We examined Cunninghamella elegans to determine its
ability to transform amoxapine, a tricyclic antidepressant belonging to the dibenzoxazepine class of drugs. Approximately 57% of the exogenous amoxapine was metabolized to three metabolites that were isolated by
high-performance liquid chromatography and were identified by nuclear
magnetic resonance and mass spectrometry as 7-hydroxyamoxapine (48%),
N-formyl-7-hydroxyamoxapine (31%), and
N-formylamoxapine (21%). 7-Hydroxyamoxapine, a mammalian
metabolite with biological activity, now can be produced in milligram
quantities for toxicological evaluation.
0099-2240/00/$04.00+0
Transformation of Amoxapine by
Cunninghamella elegans
*
Corresponding author. Mailing address: Division of
Microbiology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079-9502. Phone: (870) 543-7341. Fax:
(870) 543-7307. E-mail: CCerniglia{at}nctr.fda.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»